Skip to main content
Smart Investors Daily
RK

OTC · RKAGY

RHON-KLINIKUM AG Unsponsored ADR

Healthcare · Medical - Care Facilities

$8.16

Up+$0.00 (+0.00%)

Updated Nov 5, 2026, 12:40 AM

SID Score

4.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
989.34M
P/E ratio
23.01
Dividend yield
0.70%
52-week range
— – —
Volume
100
Avg. volume
9.02

Price performance · RKAGY

RKAGY price history

1M range · 0 trading sessions · Daily adjusted prices

RKAGY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest RKAGY news

The latest Smart Investors Daily articles mentioning RKAGY.

RKAGY research

Overview

Company profile and research snapshot.

Company profile

RHOEN KLINIKUM UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
RKAGY recent ratings
DateFirmRatingTarget
Aug 26, 2026LANDESBANK BADEN-WUERTTEMBERGHold—
May 15, 2026LANDESBANK BADEN-WUERTTEMBERGHold—
May 14, 2026LANDESBANK BADEN-WUERTTEMBERGHold—
Feb 17, 2026SOLVENTIS RESEARCHBuy—
Feb 16, 2026SOLVENTIS RESEARCHBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 17, 2026

RHÖN KLINIKUM (XTRA:RHK) Stock May Trade At A Premium After A 30% Run

RHÖN-KLINIKUM has delivered a 30.3% share price gain over the past three years, which naturally puts the focus on whether that move is supported by the hospital operator's cash generation. With the stock recently closing at €14.50, the key issue now is how that market price lines up against what its cash flows suggest the business might be worth. The 30.3% return over three years puts real weight on the question of whether RHÖN-KLINIKUM's current valuation is grounded in its underlying cash...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.